The Aperio Blog
Aperio is Proud to Sponsor NCBIO’s Life Science & Luncheon Forum
January 10, 2019
There are several new therapies reshaping the way we treat disease. Aperio is proud to sponsor NCBIO’s Life Science and Luncheon Forum on January 31st where leaders from the local Raleigh-Durham community will come together to discuss their cutting-edge technologies in gene therapy, cell therapy, gene editing, and nanotechnology. Speakers will discuss how these therapies work, what companies need to succeed, and pricing/reimbursement models.
Title: Emerging Therapies – Reshaping How We Treat Disease
Date: January 31, 2019
Time: 11:30 a.m. – 1:30 p.m.
Location: NC Biotechnology Center
Panelists:
Michael Dombeck, Vice President of Business Development, Precision BioSciences
Tom Jede, Site Head and Senior Director, Vector Manufacturing, bluebird bio
Susan Nichols, Chief Executive Officer, Falcon Therapeutics
Alden Pritchard, Chief Executive Officer, Kaio Therapy
This is a members only event. For additional information on this event or to register, please click here.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes offers essential services for today’s complex, data-intensive oncology and rare disease clinical trials: rock-solid fit-for-purpose database development and management, unmatched analytics expertise, and powerful holistic tools that deliver the most coherent and actionable views of essential data. Just as important, in an industry flooded with promises, we make only one: We tell the truth, no matter what.
